DK0747385T3 - Prodrugs af paclitaxel-derivater - Google Patents

Prodrugs af paclitaxel-derivater

Info

Publication number
DK0747385T3
DK0747385T3 DK96109044T DK96109044T DK0747385T3 DK 0747385 T3 DK0747385 T3 DK 0747385T3 DK 96109044 T DK96109044 T DK 96109044T DK 96109044 T DK96109044 T DK 96109044T DK 0747385 T3 DK0747385 T3 DK 0747385T3
Authority
DK
Denmark
Prior art keywords
prodrugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
DK96109044T
Other languages
Danish (da)
English (en)
Inventor
Dolatrai M Vyas
John F Kadow
Paul M Scola
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0747385T3 publication Critical patent/DK0747385T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
DK96109044T 1995-06-06 1996-06-05 Prodrugs af paclitaxel-derivater DK0747385T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
DK0747385T3 true DK0747385T3 (da) 2002-12-16

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96109044T DK0747385T3 (da) 1995-06-06 1996-06-05 Prodrugs af paclitaxel-derivater

Country Status (23)

Country Link
EP (1) EP0747385B1 (fr)
JP (1) JPH08337589A (fr)
KR (1) KR100375956B1 (fr)
CN (1) CN1066151C (fr)
AR (1) AR002756A1 (fr)
AT (1) ATE222259T1 (fr)
AU (1) AU695959B2 (fr)
CA (1) CA2176191A1 (fr)
CZ (1) CZ291516B6 (fr)
DE (1) DE69622933T2 (fr)
DK (1) DK0747385T3 (fr)
ES (1) ES2181824T3 (fr)
HU (1) HUP9601524A3 (fr)
IL (1) IL118526A (fr)
MX (1) MX9601994A (fr)
NO (1) NO315233B1 (fr)
NZ (1) NZ286723A (fr)
PL (1) PL187883B1 (fr)
PT (1) PT747385E (fr)
RU (1) RU2162082C2 (fr)
SG (1) SG72692A1 (fr)
TW (1) TW354293B (fr)
ZA (1) ZA964261B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
CN1261275A (zh) * 1997-05-27 2000-07-26 巴克·诺顿药物有限公司 给予病人口服紫杉烷类药物的方法和组合物
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
WO2000048606A1 (fr) * 1999-02-18 2000-08-24 Oxigene, Inc. Compositions et procedes servant au ciblage de la destruction vasculaire
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
TR200102857T1 (tr) 2000-02-02 2002-06-21 Florida State University Research Foundation Inc. Antitümör ajanları olarak C7 karbonat ikameli taksanlar
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
JP4369237B2 (ja) * 2001-12-21 2009-11-18 エーザイ コーポレーション オブ ノース アメリカ アルコールおよびフェノールの水溶性ホスホノオキシメチル誘導体の調製法
EP1737444A4 (fr) 2004-03-05 2008-05-21 Univ Florida State Res Found Taxanes a substitution de c7 lactyloxy-
US20090130163A1 (en) * 2005-02-18 2009-05-21 Abraxis Bio Scoence, Inc. Drugs With Improved Hydrophobicity For Incorporation in Medical Devices
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
RU2420239C1 (ru) * 2009-10-21 2011-06-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения злокачественных забрюшинных опухолей у детей и подростков
US20160024084A1 (en) 2013-03-15 2016-01-28 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (fr) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Dérivés deutériés d'intédanib et leur utilisation pour le traitement de troubles prolifératifs
US20180318268A1 (en) * 2015-11-19 2018-11-08 Biohaven Pharmaceutical Holding Company Ltd. Amine prodrugs of pharmaceutical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
MX9308012A (es) * 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (fr) * 1993-08-17 2000-05-16 Jerzy Golik Esters phosphonooxymethyliques de derives de taxane

Also Published As

Publication number Publication date
AR002756A1 (es) 1998-04-29
EP0747385B1 (fr) 2002-08-14
TW354293B (en) 1999-03-11
AU695959B2 (en) 1998-08-27
MX9601994A (es) 1997-08-30
CN1066151C (zh) 2001-05-23
KR970000222A (ko) 1997-01-21
HUP9601524A3 (en) 2000-03-28
CN1144805A (zh) 1997-03-12
PL314637A1 (en) 1996-12-09
HUP9601524A2 (en) 1997-05-28
NO962231D0 (no) 1996-05-31
NO315233B1 (no) 2003-08-04
SG72692A1 (en) 2000-05-23
NZ286723A (en) 1998-03-25
DE69622933T2 (de) 2003-04-24
JPH08337589A (ja) 1996-12-24
RU2162082C2 (ru) 2001-01-20
IL118526A (en) 2001-05-20
HU9601524D0 (en) 1996-07-29
PL187883B1 (pl) 2004-10-29
ES2181824T3 (es) 2003-03-01
NO962231L (no) 1996-12-09
ATE222259T1 (de) 2002-08-15
PT747385E (pt) 2002-11-29
DE69622933D1 (de) 2002-09-19
IL118526A0 (en) 1996-10-16
EP0747385A1 (fr) 1996-12-11
ZA964261B (en) 1997-11-27
AU5471896A (en) 1996-12-19
CZ291516B6 (cs) 2003-03-12
CZ156396A3 (en) 1996-12-11
CA2176191A1 (fr) 1996-12-07
KR100375956B1 (ko) 2003-04-21

Similar Documents

Publication Publication Date Title
DK0747385T3 (da) Prodrugs af paclitaxel-derivater
DK0955973T3 (da) Reduktion af dilatatorlösnelseskraft
DK0851855T3 (da) Derivater af melatonin deraf som lægemiddel
DK0833828T3 (da) Rapamycinderivater
DK0977748T3 (da) Substituerede benzopyranderivater tilbehandling af inflammation
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
DE69522717D1 (de) Chinazolinderivate
DE69611361D1 (de) Chinazolin-derivate
DE69610698D1 (de) Chinazolin-derivate
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO964667D0 (no) Purin-6-on-derivater
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
ATE224891T1 (de) Chromon-derivate
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
DK0681580T3 (da) Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider
BR9609723A (pt) Derivados da tricetona
ATE225347T1 (de) Aza-anthracyclinone-derivate
EP0804205A4 (fr) Derives de 4-aza-19-norandrostane
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate